Verse T, Schwalb J, Hörmann K, Stuck B A, Maurer J T
Universitäts-Hals-Nasen-Ohren-Klinik Mannheim, Mannheim.
HNO. 2003 Dec;51(12):966-70. doi: 10.1007/s00106-003-0842-x. Epub 2003 Jun 18.
Transcutaneous electrical stimulation while asleep has been used to treat obstructive sleep apnea (OSA), although without convincing results. Modern strategies consist of electrical muscle training for a number of weeks during wakefulness rather than stimulation during sleep.
The purpose of this study was to assess the practicability, safety, and efficacy of a new device, SilentOne (Imperpuls, Chemnitz, Germany).
Fifteen patients with various degrees of OSA used transcutaneous submental electrical stimulation therapy for 4-5 weeks every day, day and night. A patient's diary recorded practicability and potential adverse events. Respiratory parameters were recorded by fully attended polysomnography in the sleep lab. Daytime sleepiness and snoring were assessed by questionnaires.
The apnea-hypopnea-index decreased from 29.2 before to 21.2 after therapy (P<0.05). Daytime sleepiness improved significantly (P<0.01) as did snoring (P<0.005). CONCLUSIONS. Transcutaneous electrical stimulation therapy using SilentOne proved to be safe, easy to use, and potent. However, therapy showed a limited cure rate.
睡眠期间的经皮电刺激已被用于治疗阻塞性睡眠呼吸暂停(OSA),尽管结果并不令人信服。现代策略包括在清醒期间进行数周的肌肉电刺激训练,而非在睡眠期间进行刺激。
本研究旨在评估一种新型设备SilentOne(德国开姆尼茨的Imperpuls公司生产)的实用性、安全性和有效性。
15例不同程度的阻塞性睡眠呼吸暂停患者日夜每天使用经皮颏下电刺激疗法4 - 5周。患者日记记录实用性和潜在不良事件。睡眠实验室通过全夜多导睡眠监测记录呼吸参数。通过问卷调查评估日间嗜睡和打鼾情况。
呼吸暂停低通气指数从治疗前的29.2降至治疗后的21.2(P<0.05)。日间嗜睡情况显著改善(P<0.01),打鼾情况也是如此(P<0.005)。结论:使用SilentOne进行经皮电刺激疗法被证明是安全、易于使用且有效的。然而,该疗法的治愈率有限。